Bleeding control treatment during facelift surgery

This trial was testing tranexamic acid (TXA), a medication that helps reduce bleeding, when applied directly to the skin during facelift surgery. Researchers wanted to see if this medication could help decrease bleeding during and after the procedure, and they compared it to a placebo (salt water) applied to the other side of the face. Because each patient's two sides were treated differently, each person essentially served as their own comparison.

Although this medication has been used safely in many types of surgery for decades and is recommended by major medical organizations, it is not yet officially approved by the FDA specifically for use during facelift surgery. This trial aimed to gather evidence about whether the treatment works safely and effectively when applied locally to the face, rather than given through the bloodstream.